Tabner AJ, Johnson GD, Fakis A, Surtees J, Lennon RI. β-Adrenoreceptor agonists in the management of pain associated with renal colic: a systematic review.
BMJ Open 2016;
6:e011315. [PMID:
27324714 PMCID:
PMC4916590 DOI:
10.1136/bmjopen-2016-011315]
[Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
Abstract
OBJECTIVES
To determine whether β-adrenoreceptor agonists are effective analgesics for patients with renal colic through a systematic review of the literature.
SETTING
Adult emergency departments or acute assessment units.
PARTICIPANTS
Human participants with proven or suspected renal colic.
INTERVENTIONS
β-adrenoreceptor agonists.
OUTCOME MEASURES
Primary: level of pain at 30 min following administration of the β-agonist. Secondary: level of pain at various time points following β-agonist administration; length of hospital stay; analgesic requirement; stone presence, size and position; degree of hydronephrosis.
RESULTS
256 records were screened and 4 identified for full-text review. No articles met the inclusion criteria.
CONCLUSIONS AND IMPLICATIONS
There is no evidence to support or refute the proposed use of β-agonists for analgesia in patients with renal colic. Given the biological plausibility and existing literature base, clinical trials investigating the use of β-adrenoreceptor agonists in the acute setting for treatment of the pain associated with renal colic are recommended.
TRIAL REGISTRATION NUMBER
CRD42015016266.
Collapse